Impact of Atopic Dermatitis on Adolescents and Families: A Mixed‐Method Systematic Review

Abstract

AimsTo summarise the evidence regarding the impact of atopic dermatitis on adolescents and their families as well as their healthcare needs and to propose a nursing care plan based on the findings.DesignMixed‐method systematic review.MethodsTwenty‐four studies were included, of which 19 were quantitative and 5 were qualitative. The quality of the studies was assessed using the Mixed Methods Assessment Tool. The synthesis method used was data‐driven convergent synthesis design.Data SourcesA systematic search was carried out in CINAHL, Embase, MEDLINE, PsycInfo and Web of Science without language restrictions from 1 January 2013 to 30 April 2023.ResultsThe quality of life of adolescents with atopic dermatitis and their families are impaired. The more the severity of the condition, the greater the impact for them and their families. Atopic dermatitis impacts adolescents' sleep (due to itching), behaviour, mental well‐being, social and school life. Likewise, parents' sleep, free time, interpersonal relationships and work life are affected by caring for their adolescents.ConclusionAdolescents and their families encounter numerous challenges managing and living with atopic dermatitis on a daily basis. The condition has a widespread impact on adolescents and parents' quality of life across home, work and school settings. In the family, there was also an alteration in the functioning and relationships between its members.Implications for the Profession and/or Patient CareThis review reveals the burden of atopic dermatitis for adolescents and families and the need for comprehensive support. Greater awareness among healthcare professionals of the impacts may help promote an evidence‐based approach that supports the whole family. Based on these findings, we propose a nursing care plan based on the NANDA taxonomy to promote better healthcare provision for adolescents and families.Reporting MethodThis review adheres to PRISMA guidelines.Patient or Public ContributionNo patient or public contribution.Review Registration (PROSPERO According to JAN Guidelines)CRD42023435352.